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Manipulation of Genome Integrity Signaling Axes Contributing to Prostate Cancer 
Aggressiveness 
Frank Duan, Dr. Veronica Rodriguez-Bravo* 
Introduction: Prostate cancer (PC) is one of the leading causes of death in men, and 
despite current treatment options patients can develop aggressive disease that spreads 
to other parts of the body. Little research has focused to date on the effect of 
centrosome biology in the pathogenesis of PC. 
Methods: Two metastatic PC cell lines, DU145 and 22Rv1, as well as highly aggressive 
derivatives generated in Dr. Rodriguez-Bravo lab (docetaxel-resistant; (DR) variants) 
were compared through various experiments to determine differences in centrosome 
proteins expression and functionality. All cells (DU145 /DR and 22Rv1 /DR) underwent 
electroporations with siRNAs to knockout one of the centrosomal target genes (STIL) 
and were compared to siRNA controls (not targeting any human gene). Subsequently, 
western blots, RT-PCRs, colony formation assays, and immunofluorescence 
microscopy were used to analyze the differences between controls and STIL 
knockdowns and between different cell lines. 
Results: Analysis of the experiments performed suggest that there is a greater effect of 
the STIL knockdown than the siRNA control in decreasing cell proliferation in PC cells. 
There was also insufficient evidence to determine if there was a difference between the 
parental and DR cells.  
Discussion: There was statistically significant evidence that knockout of STIL 
decreased cell proliferation of metastatic PC cells DU154 and 22Rv1. This suggests a 
potential role between centrosome regulating mechanisms and the aggressiveness of 
PC cells. Future research could aim to determine the extent of the effect of the 
knockdown and potentially be exploited in the future of treatments for late-stage PC.  
